Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
HER2-Positive Gastric Cancer
... posed by gastric cancers that overexpress the human epidermal growth factor receptor 2 (HER2) protein. These advancements hold significant promise for improving patient outcomes, transforming the diagnosis, treatment, and prognosis of HER2-positive gastric cancer. The ... Read More
-
Retinopathy of Prematurity – Epidemiology Forecast– 2032
... of 2019–2032. The risk factor for developing Retinopathy of Prematurity (ROP) is the baby’s age and weight at birth. Especially children with gestational age at birth below 31 weeks or a birth weight of less ... Read More
-
Antimicrobial Susceptibility Tester Market
... traditional medicines. Fetal diseases and blood-borne diseases are spreading very fast due to environmental changes such as global warming and others. For controlling such diseases, research is being performed to find out effective medicines, antibiotics, ... Read More
-
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
... (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest ... Read More
-
US Urinary Tract Infection Therapeutics outlook to 2028
... a huge problem in the US. US typically see more than 8 million cases of UTIs every year. According to Ken Research, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at ... Read More
-
2023 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Global Recession Risk Impact
... growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
... worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, ... Read More
-
Live Biotherapeutic Products and Microbiome Manufacturing Market (2nd Edition), 2022-2035
... growing markets within the pharmaceutical industry in the coming years. Specifically, in 2020, around 575 IND applications were filed for such therapies, targeting a myriad of diseases indications, including autoimmune, gastrointestinal, infectious, metabolic and oncological ... Read More
-
United States Pain Management Therapeutics Market, Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Research. Physical and mental pain has a significant influence on life. It can hinder our daily activities, limit our mobility, and dampen our spirits. Advancements in medical technology and growing awareness have opened up new ... Read More
-
Global Cardiovascular and Cerebrovascular Diseases Market (2023 Edition): Analysis By Drug Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2029
... and Cerebrovascular Market (2023 Edition)” which provides a complete analysis of the global Cardiovascular and Cerebrovascular industry by Drug Type (Antiplatelet Agents, Anticoagulants, Antihypertensive Agents, Statins, Other Drugs) and By Indication (Hypertension, Atrial Fibrillation, Stroke, ... Read More
-
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035
... to account for 12.2% of the global death rate, in 2030. In this context, several research initiatives are underway to identify an approach that allows effective delivery of the target medication directly into the brain. ... Read More
-
Global Pompe Disease Therapeutics Market - 2023-2030
... The global Pompe disease therapeutics market is expected to exhibit a CAGR of 4.3% during the forecast period (2023-2030). Pompe disease is an inherited lysosomal condition induced by a lack of the enzyme acid alpha-glucosidase ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
... Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the dyslipidemia market through 2032. Examples of key findings from this report include the following - 2022 base year sales within the dyslipidemia market ... Read More
-
NASH Treatment & Therapeutics Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Prevalence of Non-alcoholic Steatohepatitis (NASH) ... Read More
-
Global Pancreatic Cancer Market - 2023-2030
... Pancreatic Cancer market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The pancreas can develop both malignant and non-cancerous tumors, among other growths. Pancreatic ductal adenocarcinoma, the most prevalent form ... Read More
-
Site Management Organizations Market, 2021-2035
... 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. However, the conduct of such trials is ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include - Disease Landscape Disease Overview Epidemiology Overview Treatment Overview ... Read More
-
Liver Diseases Therapeutics Market, Therapy Type (Anti-Rejection Drugs/Immunosuppressant’s, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, Immunoglobulin’s, Corticosteroids)
... Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Liver is the largest organ of the human body. It helps to digest food, store energy, and remove poisons. There are ... Read More
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
... projected to reach USD 4.5 million by 2028 from USD 2.0 billion in 2023, at a CAGR of 17.5%. The key factors driving the growth of the metagenomic sequencing market are the continuous technological innovations ... Read More
-
Sinusitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... a condition characterized by inflammation or swelling of the sinuses, has become a notable healthcare challenge, causing discomfort and decreased quality of life for patients. The condition, which often presents symptoms such as nasal congestion, ... Read More
-
Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, Peptide); By Application (Diagnostics, Therapeutics, Research & Developments, Others); By Region, And Segment Forecasts, 2023 - 2032
... expected to reach USD 16.33 billion by 2032, according to a new study by Polaris Market Research. The report “Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, and Peptide); By Application ... Read More
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Global Hereditary Angioedema Therapeutics Market 2023-2027
... hereditary angioedema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Metabolism Drugs Market Size study & Forecast, by Drug Type (Antidiabetic Drugs, Lipid Lowering Drugs, Anti-Obesity Drugs, Thyroid Hormone Drugs, Others) by Indication (Diabetes, Hyperlipidaemia, Obesity, Hypothyroidism) and Regional Analysis, 2023-2030
... Market is valued approximately at USD 16.10 billion in 2022 and is anticipated to grow with a growth rate of more than 6.50% over the forecast period 2023-2030. A metabolism drug refers to a medication ... Read More
Research Assistance
